Alcor member A-2811, a confidential, neurocryopreservation member, was pronounced legally deceased on October 17, 2018, in Scottsdale, Arizona and became Alcor’s 163rd patient.

This patient was the father of an existing Alcor member who had relocated his father to Scottsdale in order to prevent ischemic damage associated with transit times and to take advantage of the best protocols Alcor has to offer. The member had stage 4 cancer that had metastasized.

International Cryomedicine Experts (ICE) was deployed to standby and stabilize the member. The standby lasted five days. There were considerable challenges with a skilled nursing facility that would not cooperate, but the member was successfully relocated to a hospice facility in time to mount a successful standby and stabilization.